<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#Cover" roleURI="http://okyopharma.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#BalanceSheets" roleURI="http://okyopharma.com/role/BalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#StatementsOfOperationsAndComprehensiveLoss" roleURI="http://okyopharma.com/role/StatementsOfOperationsAndComprehensiveLoss" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#StatementsOfShareholdersEquity" roleURI="http://okyopharma.com/role/StatementsOfShareholdersEquity" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#StatementsOfCashFlows" roleURI="http://okyopharma.com/role/StatementsOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#MaterialCybersecurityIncidentDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ReportingEntity" roleURI="http://okyopharma.com/role/ReportingEntity" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#AccountingPolicies" roleURI="http://okyopharma.com/role/AccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#CriticalAccountingJudgementsAndKeySourcesOfEstimationUncertainty" roleURI="http://okyopharma.com/role/CriticalAccountingJudgementsAndKeySourcesOfEstimationUncertainty" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#OperatingExpenses" roleURI="http://okyopharma.com/role/OperatingExpenses" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#SegmentalReporting" roleURI="http://okyopharma.com/role/SegmentalReporting" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#EmployeesIncludingOfficersExecutiveAndNon-executiveDirectors" roleURI="http://okyopharma.com/role/EmployeesIncludingOfficersExecutiveAndNon-executiveDirectors" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#RemunerationOfKeyManagementPersonnel" roleURI="http://okyopharma.com/role/RemunerationOfKeyManagementPersonnel" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#Taxation" roleURI="http://okyopharma.com/role/Taxation" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#FinanceIncomeAndCosts" roleURI="http://okyopharma.com/role/FinanceIncomeAndCosts" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#PropertyPlantAndEquipment" roleURI="http://okyopharma.com/role/PropertyPlantAndEquipment" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#PrepaidExpensesAndOtherReceivables" roleURI="http://okyopharma.com/role/PrepaidExpensesAndOtherReceivables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#TradeAndOtherPayables" roleURI="http://okyopharma.com/role/TradeAndOtherPayables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#CapitalAndReserves" roleURI="http://okyopharma.com/role/CapitalAndReserves" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ShareOptionsAndWarrants" roleURI="http://okyopharma.com/role/ShareOptionsAndWarrants" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#FinancialInstruments" roleURI="http://okyopharma.com/role/FinancialInstruments" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#RelatedPartyTransactions" roleURI="http://okyopharma.com/role/RelatedPartyTransactions" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#BasicAndDilutedLossPerShare" roleURI="http://okyopharma.com/role/BasicAndDilutedLossPerShare" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#Leases" roleURI="http://okyopharma.com/role/Leases" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#AuditorsRemuneration" roleURI="http://okyopharma.com/role/AuditorsRemuneration" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#CashAndCashEquivalentsAndShortTermInvestments" roleURI="http://okyopharma.com/role/CashAndCashEquivalentsAndShortTermInvestments" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ConvertibleLoanInstruments" roleURI="http://okyopharma.com/role/ConvertibleLoanInstruments" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#CommitmentsAndContingencies" roleURI="http://okyopharma.com/role/CommitmentsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#PostBalanceSheetEvents" roleURI="http://okyopharma.com/role/PostBalanceSheetEvents" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#AccountingPoliciesPolicies" roleURI="http://okyopharma.com/role/AccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#AccountingPoliciesTables" roleURI="http://okyopharma.com/role/AccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#OperatingExpensesTables" roleURI="http://okyopharma.com/role/OperatingExpensesTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#EmployeesIncludingOfficersExecutiveAndNon-executiveDirectorsTables" roleURI="http://okyopharma.com/role/EmployeesIncludingOfficersExecutiveAndNon-executiveDirectorsTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#RemunerationOfKeyManagementPersonnelTables" roleURI="http://okyopharma.com/role/RemunerationOfKeyManagementPersonnelTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#TaxationTables" roleURI="http://okyopharma.com/role/TaxationTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#FinanceIncomeAndCostsTables" roleURI="http://okyopharma.com/role/FinanceIncomeAndCostsTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#PropertyPlantAndEquipmentTables" roleURI="http://okyopharma.com/role/PropertyPlantAndEquipmentTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#PrepaidExpensesAndOtherReceivablesTables" roleURI="http://okyopharma.com/role/PrepaidExpensesAndOtherReceivablesTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#TradeAndOtherPayablesTables" roleURI="http://okyopharma.com/role/TradeAndOtherPayablesTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#CapitalAndReservesTables" roleURI="http://okyopharma.com/role/CapitalAndReservesTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ShareOptionsAndWarrantsTables" roleURI="http://okyopharma.com/role/ShareOptionsAndWarrantsTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#FinancialInstrumentsTables" roleURI="http://okyopharma.com/role/FinancialInstrumentsTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#BasicAndDilutedLossPerShareTables" roleURI="http://okyopharma.com/role/BasicAndDilutedLossPerShareTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#LeasesTables" roleURI="http://okyopharma.com/role/LeasesTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#AuditorsRemunerationTables" roleURI="http://okyopharma.com/role/AuditorsRemunerationTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#CashAndCashEquivalentsAndShortTermInvestmentsTables" roleURI="http://okyopharma.com/role/CashAndCashEquivalentsAndShortTermInvestmentsTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#CommitmentsAndContingenciesTables" roleURI="http://okyopharma.com/role/CommitmentsAndContingenciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#AccountingPoliciesDetailsNarrative" roleURI="http://okyopharma.com/role/AccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#DisclosureOfEstimatedUsefulLivesDetails" roleURI="http://okyopharma.com/role/DisclosureOfEstimatedUsefulLivesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfOperatingExpensesDetails" roleURI="http://okyopharma.com/role/ScheduleOfOperatingExpensesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfEmployeesCostAndNumberOfEmployeesExplanatoryDetails" roleURI="http://okyopharma.com/role/ScheduleOfEmployeesCostAndNumberOfEmployeesExplanatoryDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfKeyManagementPersonnelCompensationDetails" roleURI="http://okyopharma.com/role/ScheduleOfKeyManagementPersonnelCompensationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#RemunerationOfKeyManagementPersonnelDetailsNarrative" roleURI="http://okyopharma.com/role/RemunerationOfKeyManagementPersonnelDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfShareOptionsGrantedToDirectorsDetails" roleURI="http://okyopharma.com/role/ScheduleOfShareOptionsGrantedToDirectorsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfTaxCreditPeriodDetails" roleURI="http://okyopharma.com/role/ScheduleOfTaxCreditPeriodDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfTaxCreditPeriodDetailsParanthetical" roleURI="http://okyopharma.com/role/ScheduleOfTaxCreditPeriodDetailsParanthetical" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#TaxationDetailsNarrative" roleURI="http://okyopharma.com/role/TaxationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfFinanceIncomeAndCostsDetails" roleURI="http://okyopharma.com/role/ScheduleOfFinanceIncomeAndCostsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfPropertyPlantAndEquipmentDetails" roleURI="http://okyopharma.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfPropertyPlantAndEquipmentLocatedInOperatingSegmentDetails" roleURI="http://okyopharma.com/role/ScheduleOfPropertyPlantAndEquipmentLocatedInOperatingSegmentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfPrepaidExpensesAndOtherReceivablesDetails" roleURI="http://okyopharma.com/role/ScheduleOfPrepaidExpensesAndOtherReceivablesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfTradeAndOtherPayablesDetails" roleURI="http://okyopharma.com/role/ScheduleOfTradeAndOtherPayablesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfAuthorizedIssueUnlimitedNumberOfParValueSharesDetails" roleURI="http://okyopharma.com/role/ScheduleOfAuthorizedIssueUnlimitedNumberOfParValueSharesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#CapitalAndReservesDetailsNarrative" roleURI="http://okyopharma.com/role/CapitalAndReservesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfOptionsOutstandingAndWeightedAverageExercisePriceDetails" roleURI="http://okyopharma.com/role/ScheduleOfOptionsOutstandingAndWeightedAverageExercisePriceDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ShareOptionsAndWarrantsDetailsNarrative" roleURI="http://okyopharma.com/role/ShareOptionsAndWarrantsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfShareOptionsOutstandingExpiryDatesAndExercisePricesDetails" roleURI="http://okyopharma.com/role/ScheduleOfShareOptionsOutstandingExpiryDatesAndExercisePricesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfShareBasedPaymentAwardModelInputsOptionsGrantedDetails" roleURI="http://okyopharma.com/role/ScheduleOfShareBasedPaymentAwardModelInputsOptionsGrantedDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfWarrantsOutstandingAndWeightedAverageExercisePriceDetails" roleURI="http://okyopharma.com/role/ScheduleOfWarrantsOutstandingAndWeightedAverageExercisePriceDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#SummaryOfFinancialLiabilitiesBasedOnContractualUndiscountedPaymentsDetails" roleURI="http://okyopharma.com/role/SummaryOfFinancialLiabilitiesBasedOnContractualUndiscountedPaymentsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#RelatedPartyTransactionsDetailsNarrative" roleURI="http://okyopharma.com/role/RelatedPartyTransactionsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#SummaryOfIncomeAndShareDataUsedInBasicAndDilutedLossPerShareComputationsDetails" roleURI="http://okyopharma.com/role/SummaryOfIncomeAndShareDataUsedInBasicAndDilutedLossPerShareComputationsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfContractualMaturitiesOfLeaseLiabilitiesDetails" roleURI="http://okyopharma.com/role/ScheduleOfContractualMaturitiesOfLeaseLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfCompanyAuditorsFeesDetails" roleURI="http://okyopharma.com/role/ScheduleOfCompanyAuditorsFeesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfCashAndCashEquivalentDetails" roleURI="http://okyopharma.com/role/ScheduleOfCashAndCashEquivalentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfShortTermInvestmentsDetails" roleURI="http://okyopharma.com/role/ScheduleOfShortTermInvestmentsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ConvertibleLoanInstrumentsDetailsNarrative" roleURI="http://okyopharma.com/role/ConvertibleLoanInstrumentsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#ScheduleOfMilestonesPaymentDetails" roleURI="http://okyopharma.com/role/ScheduleOfMilestonesPaymentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="okyo-20260331.xsd#CommitmentsAndContingenciesDetailsNarrative" roleURI="http://okyopharma.com/role/CommitmentsAndContingenciesDetailsNarrative" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-fullShorttermInvestmentsClassifiedAsCashEquivalents" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullShorttermInvestmentsClassifiedAsCashEquivalents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_CurrentTaxationReceivable" xlink:label="loc_OKYOCurrentTaxationReceivable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_OKYOCurrentTaxationReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-fullTradeAndOtherReceivables" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullTradeAndOtherReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayables" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-fullSharePremium" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullSharePremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-fullReserveOfSharebasedPayments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullReserveOfSharebasedPayments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_ConvertibleLoanNoteReserve" xlink:label="loc_OKYOConvertibleLoanNoteReserve" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_OKYOConvertibleLoanNoteReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WarrantReserve" xlink:label="loc_ifrs-fullWarrantReserve" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullWarrantReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_ForeignCurrencyTranslationReserve" xlink:label="loc_OKYOForeignCurrencyTranslationReserve" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_OKYOForeignCurrencyTranslationReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-fullRetainedEarnings" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullRetainedEarnings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAndLiabilities" xlink:to="loc_ifrs-fullLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAndLiabilities" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000003 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingExpenseExcludingCostOfSales" xlink:label="loc_ifrs-fullOperatingExpenseExcludingCostOfSales" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-fullResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullOperatingExpenseExcludingCostOfSales" xlink:to="loc_ifrs-fullResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-fullOperatingExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullOperatingExpenseExcludingCostOfSales" xlink:to="loc_ifrs-fullOperatingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullOperatingExpenseExcludingCostOfSales" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-fullFinanceIncomeCost" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullFinanceIncomeCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullComprehensiveIncome" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-fullOtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullComprehensiveIncome" xlink:to="loc_ifrs-fullOtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/StatementsOfShareholdersEquity" xlink:title="00000004 - Statement - Consolidated Statements of Shareholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-fullAdjustmentsForSharebasedPayments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForSharebasedPayments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_AdjustmentsForChangeInFairValueOfWarrantCharge" xlink:label="loc_OKYOAdjustmentsForChangeInFairValueOfWarrantCharge" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_OKYOAdjustmentsForChangeInFairValueOfWarrantCharge" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_AdjustmentsForChangeInFairValueOfForfeitureOfOptions" xlink:label="loc_OKYOAdjustmentsForChangeInFairValueOfForfeitureOfOptions" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_OKYOAdjustmentsForChangeInFairValueOfForfeitureOfOptions" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-fullAdjustmentsForDepreciationExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForDepreciationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_ExpensesSettledInShares" xlink:label="loc_OKYOExpensesSettledInShares" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_OKYOExpensesSettledInShares" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_SharesIssuedInLieuOfConsultancyFees" xlink:label="loc_OKYOSharesIssuedInLieuOfConsultancyFees" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_OKYOSharesIssuedInLieuOfConsultancyFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_SharesIssuedInLieuOfBonus" xlink:label="loc_OKYOSharesIssuedInLieuOfBonus" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_OKYOSharesIssuedInLieuOfBonus" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_ClnFeesSettledInShares" xlink:label="loc_OKYOClnFeesSettledInShares" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_OKYOClnFeesSettledInShares" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_SharesIssuedInLieuOfInterest" xlink:label="loc_OKYOSharesIssuedInLieuOfInterest" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_OKYOSharesIssuedInLieuOfInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_ConvertibleLoanInterestAccrued" xlink:label="loc_OKYOConvertibleLoanInterestAccrued" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_OKYOConvertibleLoanInterestAccrued" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_AdjustmentsForIncreaseDecreaseInRelatedPartyPayables" xlink:label="loc_OKYOAdjustmentsForIncreaseDecreaseInRelatedPartyPayables" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_OKYOAdjustmentsForIncreaseDecreaseInRelatedPartyPayables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-fullPurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullPurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_ProceedsFromFundraisingNetAndIssuanceOfOrdinaryShares" xlink:label="loc_OKYOProceedsFromFundraisingNetAndIssuanceOfOrdinaryShares" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_OKYOProceedsFromFundraisingNetAndIssuanceOfOrdinaryShares" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_ProceedsFromConvertibleLoanNote" xlink:label="loc_OKYOProceedsFromConvertibleLoanNote" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_OKYOProceedsFromConvertibleLoanNote" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000011 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000012 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ReportingEntity" xlink:title="999013 - Disclosure - Reporting Entity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/AccountingPolicies" xlink:title="999014 - Disclosure - ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/CriticalAccountingJudgementsAndKeySourcesOfEstimationUncertainty" xlink:title="999015 - Disclosure - CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/OperatingExpenses" xlink:title="999016 - Disclosure - OPERATING EXPENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/SegmentalReporting" xlink:title="999017 - Disclosure - SEGMENTAL REPORTING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/EmployeesIncludingOfficersExecutiveAndNon-executiveDirectors" xlink:title="999018 - Disclosure - EMPLOYEES INCLUDING OFFICERS, EXECUTIVE AND NON-EXECUTIVE DIRECTORS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/RemunerationOfKeyManagementPersonnel" xlink:title="999019 - Disclosure - REMUNERATION OF KEY MANAGEMENT PERSONNEL" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/Taxation" xlink:title="999020 - Disclosure - TAXATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/FinanceIncomeAndCosts" xlink:title="999021 - Disclosure - FINANCE INCOME AND COSTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/PropertyPlantAndEquipment" xlink:title="999022 - Disclosure - PROPERTY, PLANT AND EQUIPMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/PrepaidExpensesAndOtherReceivables" xlink:title="999023 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/TradeAndOtherPayables" xlink:title="999024 - Disclosure - TRADE AND OTHER PAYABLES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/CapitalAndReserves" xlink:title="999025 - Disclosure - CAPITAL AND RESERVES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ShareOptionsAndWarrants" xlink:title="999026 - Disclosure - SHARE OPTIONS AND WARRANTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/FinancialInstruments" xlink:title="999027 - Disclosure - FINANCIAL INSTRUMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/RelatedPartyTransactions" xlink:title="999028 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/BasicAndDilutedLossPerShare" xlink:title="999029 - Disclosure - BASIC AND DILUTED LOSS PER SHARE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/Leases" xlink:title="999030 - Disclosure - LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/AuditorsRemuneration" xlink:title="999031 - Disclosure - AUDITOR&#8217;S REMUNERATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/CashAndCashEquivalentsAndShortTermInvestments" xlink:title="999032 - Disclosure - CASH AND CASH EQUIVALENTS AND SHORT TERM INVESTMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ConvertibleLoanInstruments" xlink:title="999033 - Disclosure - CONVERTIBLE LOAN INSTRUMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/CommitmentsAndContingencies" xlink:title="999034 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/PostBalanceSheetEvents" xlink:title="999035 - Disclosure - POST BALANCE SHEET EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/AccountingPoliciesPolicies" xlink:title="999036 - Disclosure - ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/AccountingPoliciesTables" xlink:title="999037 - Disclosure - ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/OperatingExpensesTables" xlink:title="999038 - Disclosure - OPERATING EXPENSES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/EmployeesIncludingOfficersExecutiveAndNon-executiveDirectorsTables" xlink:title="999039 - Disclosure - EMPLOYEES INCLUDING OFFICERS, EXECUTIVE AND NON-EXECUTIVE DIRECTORS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/RemunerationOfKeyManagementPersonnelTables" xlink:title="999040 - Disclosure - REMUNERATION OF KEY MANAGEMENT PERSONNEL (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/TaxationTables" xlink:title="999041 - Disclosure - TAXATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/FinanceIncomeAndCostsTables" xlink:title="999042 - Disclosure - FINANCE INCOME AND COSTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/PropertyPlantAndEquipmentTables" xlink:title="999043 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/PrepaidExpensesAndOtherReceivablesTables" xlink:title="999044 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/TradeAndOtherPayablesTables" xlink:title="999045 - Disclosure - TRADE AND OTHER PAYABLES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/CapitalAndReservesTables" xlink:title="999046 - Disclosure - CAPITAL AND RESERVES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ShareOptionsAndWarrantsTables" xlink:title="999047 - Disclosure - SHARE OPTIONS AND WARRANTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/FinancialInstrumentsTables" xlink:title="999048 - Disclosure - FINANCIAL INSTRUMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/BasicAndDilutedLossPerShareTables" xlink:title="999049 - Disclosure - BASIC AND DILUTED LOSS PER SHARE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/LeasesTables" xlink:title="999050 - Disclosure - LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/AuditorsRemunerationTables" xlink:title="999051 - Disclosure - AUDITOR&#8217;S REMUNERATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/CashAndCashEquivalentsAndShortTermInvestmentsTables" xlink:title="999052 - Disclosure - CASH AND CASH EQUIVALENTS AND SHORT TERM INVESTMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/CommitmentsAndContingenciesTables" xlink:title="999053 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/AccountingPoliciesDetailsNarrative" xlink:title="999054 - Disclosure - ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/DisclosureOfEstimatedUsefulLivesDetails" xlink:title="999055 - Disclosure - DISCLOSURE OF ESTIMATED USEFUL LIVES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfOperatingExpensesDetails" xlink:title="999056 - Disclosure - SCHEDULE OF OPERATING EXPENSES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfEmployeesCostAndNumberOfEmployeesExplanatoryDetails" xlink:title="999057 - Disclosure - SCHEDULE OF EMPLOYEES COST AND NUMBER OF EMPLOYEES EXPLANATORY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfKeyManagementPersonnelCompensationDetails" xlink:title="999058 - Disclosure - SCHEDULE OF KEY MANAGEMENT PERSONNEL COMPENSATION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/RemunerationOfKeyManagementPersonnelDetailsNarrative" xlink:title="999059 - Disclosure - REMUNERATION OF KEY MANAGEMENT PERSONNEL (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfShareOptionsGrantedToDirectorsDetails" xlink:title="999060 - Disclosure - SCHEDULE OF SHARE OPTIONS GRANTED TO DIRECTORS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfTaxCreditPeriodDetails" xlink:title="999061 - Disclosure - SCHEDULE OF TAX CREDIT PERIOD (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfTaxCreditPeriodDetailsParanthetical" xlink:title="999062 - Disclosure - SCHEDULE OF TAX CREDIT PERIOD (Details) (Paranthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/TaxationDetailsNarrative" xlink:title="999063 - Disclosure - TAXATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfFinanceIncomeAndCostsDetails" xlink:title="999064 - Disclosure - SCHEDULE OF FINANCE INCOME AND COSTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="loc_ifrs-fullRevenueFromInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceIncome" xlink:to="loc_ifrs-fullRevenueFromInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_FinanceCharges" xlink:label="loc_OKYOFinanceCharges" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceCosts" xlink:to="loc_OKYOFinanceCharges" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings" xlink:label="loc_ifrs-fullInterestExpenseOnBorrowings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceCosts" xlink:to="loc_ifrs-fullInterestExpenseOnBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="okyo-20260331.xsd#OKYO_InterestExpenseOnRelatedPartyLoan" xlink:label="loc_OKYOInterestExpenseOnRelatedPartyLoan" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceCosts" xlink:to="loc_OKYOInterestExpenseOnRelatedPartyLoan" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-fullFinanceIncomeCost" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceIncomeCost" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceIncomeCost" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" xlink:title="999065 - Disclosure - SCHEDULE OF PROPERTY PLANT AND EQUIPMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfPropertyPlantAndEquipmentLocatedInOperatingSegmentDetails" xlink:title="999066 - Disclosure - SCHEDULE OF PROPERTY PLANT AND EQUIPMENT LOCATED IN OPERATING SEGMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfPrepaidExpensesAndOtherReceivablesDetails" xlink:title="999067 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND OTHER RECEIVABLES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-fullTradeAndOtherReceivables" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-fullOtherReceivables" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullTradeAndOtherReceivables" xlink:to="loc_ifrs-fullOtherReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullTradeAndOtherReceivables" xlink:to="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ValueAddedTaxReceivables" xlink:label="loc_ifrs-fullValueAddedTaxReceivables" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullTradeAndOtherReceivables" xlink:to="loc_ifrs-fullValueAddedTaxReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Prepayments" xlink:label="loc_ifrs-fullPrepayments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullTradeAndOtherReceivables" xlink:to="loc_ifrs-fullPrepayments" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfTradeAndOtherPayablesDetails" xlink:title="999068 - Disclosure - SCHEDULE OF TRADE AND OTHER PAYABLES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayables" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayablesToTradeSuppliers" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayablesToTradeSuppliers" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPayables" xlink:label="loc_ifrs-fullOtherPayables" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:to="loc_ifrs-fullOtherPayables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Accruals" xlink:label="loc_ifrs-fullAccruals" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:to="loc_ifrs-fullAccruals" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="loc_ifrs-fullShorttermEmployeeBenefitsAccruals" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:to="loc_ifrs-fullShorttermEmployeeBenefitsAccruals" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfAuthorizedIssueUnlimitedNumberOfParValueSharesDetails" xlink:title="999069 - Disclosure - SCHEDULE OF AUTHORIZED ISSUE UNLIMITED NUMBER OF PAR VALUE SHARES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/CapitalAndReservesDetailsNarrative" xlink:title="999070 - Disclosure - CAPITAL AND RESERVES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfOptionsOutstandingAndWeightedAverageExercisePriceDetails" xlink:title="999071 - Disclosure - SCHEDULE OF OPTIONS OUTSTANDING AND WEIGHTED AVERAGE EXERCISE PRICE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ShareOptionsAndWarrantsDetailsNarrative" xlink:title="999072 - Disclosure - SHARE OPTIONS AND WARRANTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfShareOptionsOutstandingExpiryDatesAndExercisePricesDetails" xlink:title="999073 - Disclosure - SCHEDULE OF SHARE OPTIONS OUTSTANDING EXPIRY DATES AND EXERCISE PRICES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfShareBasedPaymentAwardModelInputsOptionsGrantedDetails" xlink:title="999074 - Disclosure - SCHEDULE OF SHARE BASED PAYMENT AWARD MODEL INPUTS OPTIONS GRANTED (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfWarrantsOutstandingAndWeightedAverageExercisePriceDetails" xlink:title="999075 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING AND WEIGHTED AVERAGE EXERCISE PRICE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/SummaryOfFinancialLiabilitiesBasedOnContractualUndiscountedPaymentsDetails" xlink:title="999076 - Disclosure - SUMMARY OF FINANCIAL LIABILITIES BASED ON CONTRACTUAL UNDISCOUNTED PAYMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-fullTradeAndOtherPayables" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinancialLiabilities" xlink:to="loc_ifrs-fullTradeAndOtherPayables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinancialLiabilities" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="999077 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/SummaryOfIncomeAndShareDataUsedInBasicAndDilutedLossPerShareComputationsDetails" xlink:title="999078 - Disclosure - SUMMARY OF INCOME AND SHARE DATA USED IN THE BASIC AND DILUTED LOSS PER SHARE COMPUTATIONS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfContractualMaturitiesOfLeaseLiabilitiesDetails" xlink:title="999079 - Disclosure - SCHEDULE OF CONTRACTUAL MATURITIES OF LEASE LIABILITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfCompanyAuditorsFeesDetails" xlink:title="999080 - Disclosure - SCHEDULE OF COMPANY AUDITORS FEES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfCashAndCashEquivalentDetails" xlink:title="999081 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfShortTermInvestmentsDetails" xlink:title="999082 - Disclosure - SCHEDULE OF SHORT TERM INVESTMENTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ConvertibleLoanInstrumentsDetailsNarrative" xlink:title="999083 - Disclosure - CONVERTIBLE LOAN INSTRUMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/ScheduleOfMilestonesPaymentDetails" xlink:title="999084 - Disclosure - SCHEDULE OF MILESTONES PAYMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://okyopharma.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999085 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
</link:linkbase>
